Pepmic Co., Ltd, founded in 2010, is a prominent player in the Biotechnology and Life Sciences industries, based in China. Under the slogan "Committed to Lifescience," Pepmic offers a diverse range of services, primarily focusing on molecular biology and immunology. Their expertise encompasses peptide synthesis, antibody development, protein expression, and gene synthesis.
Renowned for its high service standards, Pepmic provides comprehensive and integrated solutions, facilitating efficient execution of biological research projects. Their services are tailored to client needs, covering four core areas: peptide synthesis, protein expression in various cell types, and both monoclonal and polyclonal antibody production.
Although Pepmic has yet to disclose recent investment activities, their extensive scientific knowledge and functional expertise position them as a reliable partner for biotech innovations, making them an attractive prospect for potential investors seeking to invest in cutting-edge life sciences solutions.